Health Imaging December 13, 2022
As the U.S. Food and Drug Administration prepares to roll out their breast density notification rule in early 2023, experts are cautioning that careful consideration is needed in the new rule’s language.
In commentary published in JAMA, Nancy R. Kressin, PhD, of Boston University Chobanian and Avedisian School of Medicine and colleagues shared examples from their own research that portray women’s general understanding of breast density notification letters [1]. The authors explained that these notifications can sometimes leave many patients feeling even more bewildered about their mammogram results than they were before being made aware of their dense tissue.
Prior studies that Kressin was involved in suggest that some women consider breast density notification letters impersonal and confusing. This...
Today's Sponsors
Today's Sponsor